Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Hällberg, Ville ^a,b   Palomäki, Ari ^a   Lahtela, Jorma ^b,c   Voutilainen, Seppo ^d   Tarkka, Matti ^b,c   Kataja, Matti ^e   Salonen, H ^f   Aitola, K ^f   Eerikainen T ^f   Helen M ^f   Hakkinen M ^f   Karjalainen, J ^f   Lappetelainen V ^f   Puolijoki, H ^f  

^a KANTA HÄME CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f NONE

Author keywords

Coronary artery bypass grafting; Diabetes mellitus; Follow up; Metabolic syndrome; Mortality

Indexed keywords

AGED; CORONARY ARTERY BYPASS; DIABETES MELLITUS; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84892635952     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-13-25     Document Type: Article

References (31)

1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: part I: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 5:539-553.
2. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497. 10.1001/jama.285.19.2486, 11368702.
3. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2716. 10.1001/jama.288.21.2709, 12460094.
4. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. Diabetes Care 2005, 28:1769-1778. 10.2337/diacare.28.7.1769, 15983333.
5. Pohjantähti-Maaroos H, Palomäki A, Kankkunen P, Laitinen R, Husgafvel S, Oksanen K. Circulating oxidized low-density lipoproteins and arterial elasticity: comparison between men with metabolic syndrome and physically active counterparts. Cardiovasc Diabetol 2010, 9:41. 10.1186/1475-2840-9-41, 2931500, 20727144.
6. Lorenzo C, Williams K, Hunt K, Haffner S. The national cholesterol education panel-adult treatment panel III, international diabetes federation, and world health organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007, 30:8-13. 10.2337/dc06-1414, 17192325.
7. Reaven GM. The metabolic syndrome: time to get off the merry-go-round?. J Intern Med 2010, 269:127-136.
8. Kajimoto K, Kasai T, Miyauchi K, Hirose H, Yanagisawa N, Yamamoto T, Takazawa K, Niinami H, Hosoda Y, Daida H, Amano A. Metabolic syndrome predicts 10-year mortality in non-diabetic patients following coronary artery bypass surgery. Circ J 2008, 72:1481-1486. 10.1253/circj.CJ-07-0928, 18724026.
9. Yatskar L, Holper E, Bansilal S, Schwartzbard A, Lombarder M, Ramanathan K, Feit F, Fisher E, Faxon D, Hochman JS, Farkouh ME. Long-term outcomes in non-diabetic patients with metabolic syndrome undergoing revascularization for multi-vessel coronary artery disease. Atherosclerosis 2008, 198:389-395. 10.1016/j.atherosclerosis.2007.09.046, 18061192.
10. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. NEJM 1998, 339:229-234. 10.1056/NEJM199807233390404, 9673301.
11. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART study investigators Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952. 10.1016/S0140-6736(04)17018-9, 15364185, INTERHEART study investigators.
12. Herliz J, Wognsen GB, Emanuelsson H, Haglid M, Karlson BW, Karlson T, Albertsson P, Westberg S. Mortality and morbidity in diabetic and non-diabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care 1996, 19:698-703. 10.2337/diacare.19.7.698, 8799622.
13. Carson JL, Scholz PM, Chen YA, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002, 40:418-423. 10.1016/S0735-1097(02)01969-1, 12142105.
14. Alserius T, Hammar N, Nordqvist T, Ivert T. Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes. Am Heart J 2006, 152:599-605. 10.1016/j.ahj.2006.02.010, 16923437.
15. Mohammadi S, Dagenais F, Mathieu P, Kingma JG, Doyle D, Lopez S, Baillot R, Perron J, Charbonneau E, Dumont E, Metras J, Desaulniers D, Voisine P. Long-term impact of diabetes and its comorbidities in patients undergoing isolated primary coronary artery bypass graft surgery. Circulation 2007, 116:I-220-I-225.
16. Hällberg V, Palomäki A, Kataja M, Tarkka M. Return to work after coronary artery bypass surgery: a 10-year follow-up study. Scand Cardiovasc J 2009, 43:277-284. 10.1080/14017430802506601, 18991161.
17. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): a new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612. 10.7326/0003-4819-150-9-200905050-00006, 2763564, 19414839.
18. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survay, 1988-94. Arch Intern Med 2003, 163:427-436. 10.1001/archinte.163.4.427, 3146257, 12588201.
19. Hakulinen T. On long-term relative survival rates. J Chron Dis 1977, 30:431-443. 10.1016/0021-9681(77)90036-4, 885984.
20. Kurki T, Kataja M. Preoperative prediction of postoperative morbidity in coronary artery bypass grafting. Ann Thorac Surg 1996, 61:1740-1745. 10.1016/0003-4975(96)00142-7, 8651777.
21. Cavaghan MK, Ehrmann DA, Polonsky KS. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 2000, 106:329-333. 10.1172/JCI10761, 314336, 10930434.
22. Mazurek M, Kowalczyk J, Lenarczyk R, Zielinska T, Sedkowska A, Pruszkowska-Skrzep P, Swiatkowski A, Sredniawa B, Kowalski O, Polonski L, Strojek K, Kalarus Z. The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively. Cardiovasc Diabetol 2012, 11:78. 10.1186/1475-2840-11-78, 3490817, 22741568.
23. Kuramitsu S, Yokoi H, Domei T, Nomura A, Watanabe H, Yamaji K, Soga Y, Arita T, Kondo K, Shirai S, Ando K, Sakai K, Iwabuchi M, Nosaka H, Nobuyoshi M. Impact of post-challenge hyperglycemia on clinical outcomes in japanese patients with stable angina undergoing percutaneous coronary intervention. Cardiovasc Diabetol 2013, 12:74. 10.1186/1475-2840-12-74, 3651729, 23651930.
24. Vonbank A, Saely CH, Rein P, Drexel H. Insulin resistance is significantly associated with the metabolic syndrome, but not with sonographically proven peripheral arterial disease. Cardiovasc Diabetol 2013, 12:106. 10.1186/1475-2840-12-106, 3720189, 23866050.
25. Nigam A, Bourassa MG, Fortie A, Guertin MC, Tardif JC. The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease. Am Heart J 2006, 151:514-521. 10.1016/j.ahj.2005.03.050, 16442923.
26. Barsness GW, Petersson ED, Ohman EM, Nelson CL, DeLong ER, Reves JG, Smith PK, Anderson RD, Jones RH, Mark DB, Califf RM. Relationship between diabetes and long-term survival after coronary bypass and angioplasty. Circulation 1997, 96:2551-2556. 10.1161/01.CIR.96.8.2551, 9355893.
27. Hakala T, Pitkänen O, Halonen P, Mustonen J, Turpeinen A, Hippeläinen M. Early and late outcome after coronary artery bypass surgery in diabetic patients. Scand Cardiovasc J 2005, 39:177-181. 10.1080/14017430510009113, 16146981.
28. Ketonen M, Pajunen P, Koukkunen H, Immonen-Räihä P, Mustonen J, Mähönen M, Niemelä M, Kuulasmaa K, Palomäki P, Arstila M, Vuorenmaa T, Lehtonen A, Lehto S, Miettinen H, Torppa J, Tuomilehto J, Airaksinen J, Pyörälä K, Salomaa V, for the FINMONICA/FINAMI Study Group Long-term prognosis after coronary artery surgery. Int J Card 2008, 124:72-79. for the FINMONICA/FINAMI Study Group.
29. Thourani VH, Weintraub WS, Stein B, Gebhardt SSP, Craver JM, Jones EL, Guyton RA. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999, 67:1045-1052. 10.1016/S0003-4975(99)00143-5, 10320249.
30. Pajunen P, Koukkunen H, Ketonen M, Jerkkola T, Immonen-Räihä P, Kärjä-Koskenkari P, Mähönen M, Niemelä M, Kuulasmaa K, Palomäki P, Mustonen J, Lehtonen A, Arstila M, Vuorenmaa T, Lehto S, Miettinen H, Torppa J, Tuomilehto J, Kesäniemi YA, Pyörälä K, Salomaa V. The validity of the Finnish hospital discharge register and causes of death register data on coronary heart disease. Eur J Cardiovasc Prev Rehabil 2005, 12:132-137.
31. Stimpson JP, Wilson FA, Murillo R, Pagan JA. Persistent disparities in cholesterol screening among immigrants to the United States. Int J Equity Health 2012, 12:22.